Helius Medical Technologies, Inc. Announces Proposed Public Offering
Helius Medical Technologies, Inc. - Class A (HSDT)
NASDAQ:AMEX Investor Relations:
heliusmedical.com/index.php/investor-relations/overview
Company Research
Source: GlobeNewswire
NEWTOWN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that it has commenced an underwritten public offering of shares of its Class A common stock (or pre-funded warrants to purchase common stock in lieu thereof). All of the securities in the offering will be sold by Helius. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. H.C. Wainwright & Co. is acting as sole book-running manager for the offering. Haywood Securities Inc. is acting as co-manager for the offering. Helius intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Class A common stock offered in the offering at the public offering price, less the underwriting discounts and commissions. T
Show less
Read more
Impact Snapshot
Event Time:
HSDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSDT alerts
High impacting Helius Medical Technologies, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
HSDT
News
- Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) DeviceGlobeNewswire
- Helius Medical Technologies, Inc. Announces Exploration of Strategic AlternativesGlobeNewswire
- Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity ConferenceGlobeNewswire
- Helius Medical Technologies, Inc. (NASDAQ: HSDT) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece [Financial Post (Toronto, Ontario, Canada)]Financial Post
HSDT
Earnings
- 3/28/24 - Beat
HSDT
Sec Filings
- 11/18/24 - Form 8-K
- 11/12/24 - Form 10-Q
- 11/8/24 - Form SC
- HSDT's page on the SEC website